EN
Instrument Fundamentals
| Date | Close | Change | Change (%) | Open | High | Low |
|---|
News
Biotech Stocks To Keep An Eye On - September 17th - Stock Observer
Amgen hit with lawsuit over its proposed Opdivo biosimilar
Bristol Myers Takes Legal Action Against Amgen to Block Opdivo Biosimilar, ETPharma
Leading Biotech Adopts Veeva Vault CRM To Strength Global Commercial And Launch Operations
Amgen Highlights MariTide, IMDELLTRA Pipeline Progress and Growth Priorities
What Veeva Systems (VEEV)'s Amgen CRM Rollout Means For Shareholders - Simply Wall St News
Bristol-Myers Targets Amgen's Opdivo Biosimilar in Patent Suit
FDA reduces monitoring time for Amgen's Imdelltra infusions
In pictures: Donald Trump's visit to Ireland
Graves' Orbitopathy Market to Grow from USD 2.06 Billion at a CAGR of 19.8% Through 2034 | ABNewswire
Targeting CD38 with bispecific antibody XmAb 18968 in patients with relapsed/refractory acute myeloid leukemia and T-cell acute lymphoblastic leukemia
Trump removes tariffs on Irish whiskey as his Ireland visit ends
Trump makes announcement on whiskey tariffs as he brings Irish visit to a close
Donald Trump claims he will remove tariffs from Irish whiskey in Irish Open speech
Trump Sets Off Alarm Bells With Incoherent Rant
Trump Demands Ukraine Halt Refinery Strikes as Diesel Surges
Amgen (AMGN) Fell 5% on a Drug That Isn't Even Its Own. Here's the Lp(a) Bet Now in Question.
Novartis' Failed Cholesterol Drug Trial Sends Ionis and Amgen Tumbling
U.S. President Donald Trump arrives in Ireland
Clinaptis Research publishes analysis of Lp(a)HORIZON failure & implications for Amgen's OCEAN(a) -- Clinaptis Advisors | PRLog
Clinical usability of an explainable AI decision support tool and evaluation of multimodal models in NSCLC
Jim Cramer Weighs Amgen (AMGN) After Novartis Trial Failure
Corient Private Wealth LP Decreases Position in Amgen Inc. $AMGN
Amgen Highlights 26% Growth Drivers, IMDELLTRA Momentum and MariTide Potential
Jon Rahm Waits as LIV Golf Future Hangs in Balance
AMGN Stock Sell-Off Overdone as Repatha Growth Remains Intact
Positive Lung Cancer Data Lifts the Case for Amgen and AstraZeneca
Amgen Inc. $AMGN Shares Sold by The Manufacturers Life Insurance Company
Traders Buy Large Volume of Amgen Put Options (NASDAQ:AMGN) - Stock Observer
The Manufacturers Life Insurance Company Decreases Stock Holdings in Amgen Inc. $AMGN - Stock Observer
Amgen's (AMGN) Neutral Rating Reiterated at Cantor Fitzgerald - Daily Political
Amgen (AMGN) Dips More Than Broader Market: What You Should Know
Stock Traders Buy Large Volume of Put Options on Amgen (NASDAQ:AMGN)
AMGN Downgraded by HSBC -- Price Target Lowered to $425
Here Are Thursday's Top Wall Street Analyst Research Calls: Advanced Micro Devices, Amgen, AngloGold Ashanti, Caterpillar, Chewy, Meta Platforms, Novartis, NVIDIA, SK hynix, and More
SVB Wealth LLC Decreases Position in Amgen Inc. $AMGN - Markets Daily
Sequoia Financial Advisors LLC Boosts Stock Holdings in Amgen Inc. $AMGN
National Pension Service Has $465.74 Million Stake in Amgen Inc. $AMGN
NewEdge Advisors LLC Has $33.69 Million Holdings in Amgen Inc. $AMGN
AMGN Looks 6.9% Overvalued on GF Value™ as Dividend Sustainabili
Amgen (NASDAQ:AMGN) Shares Gap Down - What's Next? - Stock Observer
SVB Wealth LLC Lowers Stake in Amgen Inc. $AMGN - Stock Observer
Amgen downgraded to Hold from Buy at HSBC
COPD Clinical Trial Pipeline Gains Momentum: 65+ Companies Lead the Charge in Pioneering New Treatments | DelveInsight | ABNewswire
Could AstraZeneca (AZN)'s Stronger Growth Make it a Better Bet than Amgen (AMGN)?
AMGEN TO PRESENT AT THE MORGAN STANLEY 24TH ANNUAL GLOBAL HEALTHCARE CONFERENCE
Amgen's Imdelltra Sales Surge 115% as Lung-Cancer Combination Meets Major Goals
Trade tiff could cost Calgary nearly $500M: officials - BNN Bloomberg
Rory McIlroy Predicts LIV Golf Departures - With DP World Tour 'In Good Spot' To Benefit
Surging Crude Oil Prices May Continue To Weigh On Wall Street
Baird Financial Group Inc. Increases Stock Holdings in Amgen Inc. $AMGN
Amgen and AstraZeneca Reveal Promising Lung Cancer Drug Combination That Enhances Survival Rates, ETPharma
Roivant Sciences (ROIV) Gets a Buy from TD Cowen
Arizona State Retirement System Has $54.17 Million Stock Holdings in Amgen Inc. $AMGN - Zolmax
Jim Cramer says investors are too focused on AI stocks. Here's where he says to look instead
SpaceX Helps Prevent Pullback With New Price Target
Amgen Falls 10% as Novartis Trial Failure Clouds a Cholesterol Drug Class; NVS Stock Drops 14%
Stocks making the biggest moves midday: AMGN, QCOM, EXPE, CRWV
AstraZeneca Falls Today Even as Imfinzi Wins a Landmark Survival Test
The 9 LIV Golfers Teeing It Up In The 2026 Amgen Irish Open
Arizona State Retirement System Has $54.17 Million Stock Holdings in Amgen Inc. $AMGN - Daily Political
Amgen (NASDAQ:AMGN) Shares Gap Down - Here's Why
Amgen And AstraZeneca's IMDELLTRA-Imfinzi Combo Shows Survival Benefit In Phase 3 ES-SCLC Study
Amgen Irish Open Tee Times 2026: Rounds One And Two
Amgen Down Nearly 7%, On Pace For Largest Percent Decrease Since March 2020 - Data Talk | Morningstar
Novartis's failed trial for cholesterol drug leads to broad biopharma selloff | Morningstar
SpaceX initiated, Intel upgraded: Wall Street's top analyst calls
Novartis pelacarsen Lp(a) trial fails, raising doubts for Amgen, Lilly
Amgen (NASDAQ:AMGN) Earns "Neutral" Rating from Cantor Fitzgerald - Markets Daily
The stock market has ignored the Iran conflict. Why that's about to change.
Here Are Tuesday's Top Wall Street Analyst Research Calls: Amgen, Baidu, Best Buy, Circle Internet, Corning, Intel, Lockheed Martin SpaceX, TeraWulf and More
Stock Futures Tumble as Crude Oil Surges Toward $100 on Iran Tensions
BMO lowers Amgen, BioNTech to Market Perform as risk-reward shifts
Markets News, Sept. 8, 2026: Dow Drops, Indexes End Lower to Start Holiday-Shortened Week; Oil Prices Rise; Shares of Amgen, Salesforce Fall
Amgen Shares Fall as Investors Assess Novartis Lp(a) Trial Result and BMO Downgrade
Amgen (NASDAQ:AMGN) Receives "Neutral" Rating from Cantor Fitzgerald - Stock Observer
Why the Dow is being dragged down by a Swiss company's bad news | Morningstar
Ameritas Advisory Services LLC Has $5.11 Million Stake in Amgen Inc. $AMGN
Rep. David Taylor Sells Off Amgen Inc. (NASDAQ:AMGN) Stock
Novartis trial failure raises stakes for Amgen and Eli Lilly in Lp(a) drug race
NVS Looks 22.5% Overvalued on GF Value™ as Dividend Sustainabili
Amgen Shares Fall as Novartis' Pelacarsen Misses Phase III Study Goal
Unlocking Opportunity: Dominate the Bi/Multispecific Drug in the Oncology Market with Confidence Now Available. Tracks 870+ Organizations and 1,400+ Drugs Across the Full Bi/Multispecific Oncology Pipeline
California State Teachers Retirement System Buys 297,430,677 Shares of Amgen Inc. $AMGN
HighTower Advisors LLC Sells 4,063 Shares of Amgen Inc. $AMGN - Stock Observer
Nilsine Partners LLC Makes New Investment in Amgen Inc. $AMGN
Amgen Inc. $AMGN Stake Boosted by Saudi Central Bank
NASDAQ 100 INDEX TODAY | NDX LIVE TICKER | NASDAQ 100 QUOTE & CHART | Markets Insider
TD Waterhouse Canada Inc. Sells 18,281 Shares of Amgen Inc. $AMGN
Amgen (NASDAQ:AMGN) Shares Sold Off Sen. Sheldon Whitehouse
MW Advisory LLC Makes New $1.05 Million Investment in Amgen Inc. $AMGN - Daily Political
AMGN Maintained by Wells Fargo -- Price Target Raised to $435
Latest news
Show more
Global Market Review: Gold Volatility and Tech Stock Surge Amidst Economic Uncertainty
September CPI Data: Inflation Hurdles, Tariff Impacts, and Fed Rate Cut Expectations
Navigating the AI Boom: Strategies for Investors Amid Nvidia's Valuation Surge
